Puxty Kathryn, van Mol Margo, Martin Delgado María Cruz, Darmon Michael, Ferrer Ricardo, Galazzi Alessandro, Kondi Entela, Russell Lene, Sancho Elena, Ostermann Marlies, Azoulay Elie, Bourne Richard S
Department of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK.
Department of Intensive Care Unit Adults, Erasmus Medical Center, Rotterdam, the Netherlands.
Intensive Care Med. 2025 May 20. doi: 10.1007/s00134-025-07938-6.
Medication interventions are fundamental to the care of the critically ill patient in the intensive care unit (ICU), relying on effective and appropriate delivery of the medication use process. Medication errors affect a high proportion of patients in the ICU. This scoping review maps the literature pertaining to medication errors and preventable adverse drug events in the adult ICU.
We searched seven electronic databases (PubMed, MEDLINE, EMBASE, CINAHL, Web of Science, Cochrane, Google Scholar), identifying 2960 records. After screening against predefined eligibility criteria, 48 records were included for data extraction.
A high variation in incidence of medication errors and preventable adverse drug events were reported, reflecting the heterogeneity in study designs, surveillance methods and preventability assessments. Associated risks factors include patient (high severity of illness, older age), clinical (renal dysfunction, prolonged ICU stay), staff (staff inexperience, role overload), environmental (interruptions, transfer of care) in addition to high-risk medications. The rate of serious or life-threatening harm was low at 1-5% of all medication errors. Half (n = 11, 55%) of the interventions or mitigation practices were focused on the medication prescription phase.
Most medication errors in ICU are identified and intercepted by systems and staff. A minority lead to preventable patient harm and increased length of stay. Decision support embedded in e-prescribing systems, medication reconciliation and review processes and clinical pharmacist activities reduce medication errors and patient harm.
药物干预是重症监护病房(ICU)中重症患者护理的基础,依赖于药物使用过程的有效且恰当实施。用药错误在ICU患者中影响比例较高。本综述梳理了与成人ICU用药错误和可预防的药物不良事件相关的文献。
我们检索了七个电子数据库(PubMed、MEDLINE、EMBASE、CINAHL、Web of Science、Cochrane、谷歌学术),共识别出2960条记录。根据预先设定的纳入标准进行筛选后,纳入48条记录进行数据提取。
报告的用药错误和可预防的药物不良事件发生率差异很大,这反映出研究设计、监测方法和可预防性评估的异质性。相关风险因素包括患者因素(疾病严重程度高、年龄较大)、临床因素(肾功能不全、ICU住院时间延长)、工作人员因素(经验不足、工作负荷过重)、环境因素(干扰、护理交接)以及高风险药物。严重或危及生命的伤害发生率较低,占所有用药错误的1 - 5%。一半(n = 11,55%)的干预措施或缓解措施集中在药物处方阶段。
ICU中的大多数用药错误被系统和工作人员识别并拦截。少数错误会导致可预防的患者伤害和住院时间延长。电子处方系统中嵌入的决策支持、用药核对与审查流程以及临床药师活动可减少用药错误和患者伤害。